Flächendeckende Anwendung von Immuntherapien in Deutschland
摘要
Immunotherapy, alongside surgical resection, radiotherapy, and systemic antitumor therapy, has become an integral part of cancer treatment. From 2020 to 2023, its use has continued to increase for all types of cancer. Regarding the types of immunotherapy and individual substances, there are substantial differences depending on the location of the tumors. Furthermore, the use of immunotherapy outside the terms of its license (off-label) could be observed.